Vericel (US:VCEL)2023-11-08 15:18Financial Performance - Total revenue for Q3 2023 was $45.6 million, an 18% increase compared to $38.6 million in Q3 2022[3, 6] - Year-to-date total revenue increased 19% to $132.5 million[4] - Adjusted EBITDA for Q3 2023 was $5.4 million, a 64% increase compared to $3.3 million in Q3 2022[3, 6] - Net loss per share (diluted) for Q3 2023 was ($0.08) compared to ($0.14) in Q3 2022[6] - The company had approximately $149 million in cash, restricted cash, and investments as of September 30, 2023[6] Product Performance - MACI third-quarter revenue increased 21% to $37.6 million[4, 5] - NexoBrid generated $0.6 million in revenue in Q3 2023[3, 5] - Epicel generated $7.4 million in revenue in Q3 2023[3, 5] Guidance - The company increased its full-year 2023 net revenue guidance to $192.5-$197.5 million[7, 8] - MACI revenue is projected to be $160-$164 million for the full year 2023[8] - Burn Care revenue is projected to be $32.5-$33.5 million for the full year 2023[8]